These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17040368)

  • 1. Hepatotoxicity and valproate therapy.
    Betrosian A; Frantzeskaki F
    Intern Med J; 2006 Nov; 36(11):752-4. PubMed ID: 17040368
    [No Abstract]   [Full Text] [Related]  

  • 2. Valproic-acid-induced thrombocytopenia and hepatotoxicity: discontinuation of treatment?
    Lackmann GM
    Pharmacology; 2004 Feb; 70(2):57-8. PubMed ID: 14685007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproic acid administration for hepatic fibrosis: a balance between antifibrotic efficacy and hepatotoxicity.
    Ikura Y; Iwasa Y; Ueda M
    Hepatology; 2010 Jun; 51(6):2227-8; author reply 2228. PubMed ID: 20513011
    [No Abstract]   [Full Text] [Related]  

  • 4. [Valproic acid induced-idiosyncratic hepatotoxicity].
    Mata Zubillaga D; Prieto Espuñes S; Ferrero de la Mano L; Herrero Mendoza B
    An Pediatr (Barc); 2008 Nov; 69(5):492-3. PubMed ID: 19128756
    [No Abstract]   [Full Text] [Related]  

  • 5. Valproic-acid-associated pancreatitis and hepatic toxicity in children with endstage renal disease.
    Levin TL; Berdon WE; Seigle RR; Nash MA
    Pediatr Radiol; 1997 Feb; 27(2):192-3. PubMed ID: 9028861
    [No Abstract]   [Full Text] [Related]  

  • 6. [Severe liver damage following administration of valproic acid (Depakine)].
    Coeckelberghs M; van Caillie-Bertrand M; Bultinck J; Clara R
    Ned Tijdschr Geneeskd; 1980 Aug; 124(34):1428-31. PubMed ID: 6774268
    [No Abstract]   [Full Text] [Related]  

  • 7. Evidence for a potential protective effect of carnitine-pantothenic acid co-treatment on valproic acid-induced hepatotoxicity.
    Felker D; Lynn A; Wang S; Johnson DE
    Expert Rev Clin Pharmacol; 2014 Mar; 7(2):211-8. PubMed ID: 24450420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fatal hepatic necrosis during treatment with sodium valproate].
    Miguil M; Chlihi A; Mjahed K; Sarf I; Moutawakkil S; Benaguida M
    Cah Anesthesiol; 1995; 43(3):325-6. PubMed ID: 7583902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium valproate and hepatotoxicity in epileptics.
    Beran RG; Rischbieth RH
    Med J Aust; 1979 Dec; 2(11):603-4. PubMed ID: 119151
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of L-carnitine treatment for valproate-induced hepatotoxicity.
    DeVivo DC
    Neurology; 2002 Feb; 58(3):507-8. PubMed ID: 11839873
    [No Abstract]   [Full Text] [Related]  

  • 11. Remission of West syndrome associated with valproate hepatotoxicity.
    Go T
    Brain Dev; 2002 Jun; 24(4):257-9. PubMed ID: 12015170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproate-induced worsening of seizures: clue to underlying diagnosis.
    Dhamija R; Gavrilova RH; Wirrell EC
    J Child Neurol; 2011 Oct; 26(10):1319-21. PubMed ID: 21454832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproic acid-induced DRESS syndrome with acute liver failure.
    van Zoelen MA; de Graaf M; van Dijk MR; Bogte A; van Erpecum KJ; Rockmann H; Maarschalk-Ellerbroek LJ
    Neth J Med; 2012 Apr; 70(3):155. PubMed ID: 22516584
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hepatitis due to antiepileptic agents].
    Davion T; Capron-Chivrac D; Andrejak M; Capron JP
    Gastroenterol Clin Biol; 1985 Feb; 9(2):117-26. PubMed ID: 3920108
    [No Abstract]   [Full Text] [Related]  

  • 15. An effective assessment of valproate sodium-induced hepatotoxicity with UPLC-MS and (1)HNMR-based metabonomics approach.
    Huo T; Chen X; Lu X; Qu L; Liu Y; Cai S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Oct; 969():109-16. PubMed ID: 25168794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatal hepatotoxicity in child on phenobarbitone and sodium valproate.
    Jacobi G; Thorbeck R; Ritz A; Janssen W; Schmidts HL
    Lancet; 1980 Mar; 1(8170):712-3. PubMed ID: 6103126
    [No Abstract]   [Full Text] [Related]  

  • 17. Sodium valproate induced increased frequency of micturition and enuresis.
    Gosavi DD; Suman A; Jain M
    Indian J Pharmacol; 2013; 45(1):87-8. PubMed ID: 23543036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adding topiramate to valproate therapy may cause reversible hepatic failure.
    Bumb A; Diederich N; Beyenburg S
    Epileptic Disord; 2003 Sep; 5(3):157-9. PubMed ID: 14684351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproic acid hepatic fatalities: a retrospective review.
    Dreifuss FE; Santilli N; Langer DH; Sweeney KP; Moline KA; Menander KB
    Neurology; 1987 Mar; 37(3):379-85. PubMed ID: 3102998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproate hepatotoxicity.
    Blaw ME; Belknap WM
    Pediatr Neurol; 1985; 1(5):320. PubMed ID: 3939748
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.